Termination of a Clinical Trial. Company reserves the right to terminate any clinical trial at any time after notice to and consultation with LLS, except that in cases involving patient safety issues or if authorization to conduct such clinical trial is withdrawn by the FDA or other applicable regulatory body, prior consultation requirements to LLS shall not apply. Upon termination of a clinical trial, Company and the applicable staff shall cease the performance of the applicable clinical trial but will continue to collect such data and prepare such reports as stipulated in the applicable clinical trial protocol and approved by the applicable IRB.
Appears in 4 contracts
Samples: Definitive Agreement (Onconova Therapeutics, Inc.), Definitive Agreement (Onconova Therapeutics, Inc.), Definitive Agreement (Celator Pharmaceuticals Inc)
